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Abstract
Background: The bacterium Streptococcus pyogenes causes a variety of human diseases that range from relatively
mild skin infections to severe invasive diseases, such as acute rheumatic fever, glomerulonephritis, puerperal sepsis,
necrotizing fasciitis, meningitis, and streptococcal toxic shock syndrome. Accurate identification and typing of
group A hemolytic streptococci (GAS) is essential for epidemiological and pathogenetic studies of streptococcal
diseases. For this reason, The genetic diversity of group A streptococcal (GAS) isolates from subjects in the United
Arab Emirates with streptococcal disease was studied using emm gene sequence analysis. The emm typing system
which is based on sequence analysis of PCR products of the N-terminal hypervariable region of the M protein
gene, concurs with M serotyping almost 1:1.
Findings: A total of 38 GAS isolates were analyzed, including 35 isolates from throat and 3 from skin. Among the
38 isolates, a total of 25 different emm/st types were detected: 20 isolates (53%) belonged to 16 validated standard
reference emm types and 18 isolates (47%) belonged to 9 recognized sequence types.
Conclusions: This is the first emm typing study in the United Arab Emirates to demonstrate the heterogeneity of
the GAS population.
Findings
Introduction
The bacterium Streptococcus pyogenes causes a variety of
human diseases that range from relatively mild skin
infections to severe invasive diseases, such as acute
rheumatic fever, glomerulonephritis, puerperal sepsis,
necrotizing fasciitis, meningitis, and streptococcal toxic
shock syndrome [1-3].
Accurate identification and typing of group A hemoly-
tic streptococci (GAS) is essential for epidemiological
and pathogenetic studies of streptococcal diseases.
Rebecca Lancefield developed a serotyping system based
on antigenic variation of the cell surface M protein that
has been in use since 1928. Although additional serotyp-
ing systems, i.e. T and OF typing, were developed as
valuable and practical substitutes, the M typing system
has been considered the gold standard method. How-
ever, a limited supply of antisera and the high nontype-
ability rate among isolates, in particular among isolates
f r o mt h et r o p i c s ,p r e s e n tac h a l l e n g et ou s i n gt h e
M typing system. In recent years, several molecular
typing systems have been developed as alternatives to
M typing [4-7].
Numerous typing schemes have been used to charac-
terize and measure genetic diversity among S. pyogenes
isolates. Perhaps the most common tool used today is
emm typing. The emm typing system [4,6,7], which is
based on sequence analysis of PCR products of the N-
terminal hypervariable region of the M protein gene,
concurs with M serotyping almost 1:1. In addition to its
simplicity, emm typing has allowed the detection of sev-
eral previously unknown GAS types from different geo-
graphic regions [8-11]. Knowledge of the dynamics of
emm types in a given region may shed light on the
pathogenesis of GAS infections and is critical for select-
ing appropriate vaccine candidates.
It has been noted that there are differences in the dis-
tribution of GAS M-types in tropical versus temperate
regions, since antisera produced against strains from
Europe and the United States do not recognize large
proportions of isolates from the tropics. This implies
that a multivalent vaccine targeting the most common
emm types in another part of the world may be
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any medium, provided the original work is properly cited.ineffective in the tropics. In this study, we surveyed the
genetic diversity of GAS in the UAE using emm gene
sequence analysis. We wished to better understand the
epidemiology of this important pathogen in a country
where complications resulting from streptococcal infec-
tions are still common. This study is the first to report
emm typing results in the UAE. The findings demon-
strate the divergent features of GAS in this region.
Materials and methods
Ethical Approval
This study was reviewed and approved by Zayed Mili-
tary Hospital. Patients were managed under standard
approved hospital procedures.
Bacterial isolates
The GAS isolates in the present study were obtained in
the UAE from January 2009 to December 2009 from
patients with signs of streptococcal disease. Patients are
from different ethnic groups (multinational). A total of
38 GAS isolates were included: 35 isolates from throat
and 3 from skin. The isolates were associated with cases
of acute tonsillitis (n = 35) and impetigo (n = 3). All
GAS isolates were subjected to biochemical classification
using the VITEK 2 system (bioMérieux) and SLIDEX
STREPTO Plus latex agglutination kit (bioMérieux) to
further verify that they belonged to Streptococcus pyo-
genes (group A). This collection of isolates was tested
previously for antibiotic resistance to commonly used
antibiotics using the disk diffusion method [12].
emm typing
emm typing was performed according to the protocol
described by the Centers for Disease Control and Pre-
vention (CDC; http://www.cdc.gov/ncidod/biotech/strep/
protocols.html). DNA templates were prepared using
the QIAGEN bacterial extraction kit. Briefly, for each
isolate, about half a loop of bacterial cells was picked
from overnight growth on blood agar plates and sus-
pended in 100 μl of distilled water. This suspension was
then used for bacterial extraction according to the
instructions for the kit. The eluted DNA was used
immediately for PCR or else was stored at -20°C until
use. Primers 1 and 2, as specified by the CDC protocol,
were used for amplifying the N-terminal region of the
emm gene: primer 1, 5-TAT TCG CTT AGA AAA
TTA A-3 and primer 2, 5-GCA AGT TCT TCA GCT
TGT TT-3. AmpliTaq Gold (Applied Biosystems) PCR
reagents were used according to the manufacturer’s
instructions. Amplification was performed on a PCR
thermal cycler (GeneAmp*, PCR System 9700; Applied
Biosystems) using cycle parameters specified by the
CDC. Amplification products were purified using the
JetQuick spin column technique (Germond) according
to the manufacturer’s instructions. PCR products were
analyzed on an agarose gel to ensure the quality of the
DNA and to estimate the concentration for sequencing.
Primer emmseq2, 5-TAT TCG CTT AGA AAA TTA
AAA ACA GG-3, or primer 1 was used for sequencing
the PCR products using the BioDye Terminator Cycle
Sequencing Ready Reaction kit (version 2.0; BioSystems).
Primer 1 was used when emmseq2 sequencing did not
give good results. The sequencing reaction mixtures
were prepared according to the kit instructions using
the following parameters: 96°C for 1 min; 25 cycles of
96°C for 10 s; 50°C for 5 s; and 60°C for 4 min. The
holding temperature was 4°C. The sequencing products
were purified using ethanol sodium acetate precipitation
and subjected to automated sequence analysis on an
ABI Prism 310 Genetic Analyzer. The Geneious genetic
software program (version 4.7.5) was used to edit the
sequences. The 5’ end of the sequences was compared
to sequences in the CDC database http://www.cdc.gov/
ncidod/biotech/strep/strepblast.htm. Sequences that
match sequences in this database were checked for simi-
larity with the published sequences in the GenBank
database http://www.ncbi.nlm.nih.gov/BLAST/.
GenBank accession numbers
Sequences from the emm gene that were acquired dur-
ing this study were deposited in the GenBank under
numbers HM015360-HM015397.
Tests for significance
The level of significance was determined by calculating
the P value using the chi-square test.
Results
Emm type distribution
Table 1 shows the emm/st type, site of isolation, and
disease association of the 38 GAS isolates in this study.
“emm” refers to the type-specific sequence of one of the
standard reference GAS strains, and “st” stands for
sequence types discovered later, including novel
sequence types in the present study that await validation
by the international committee http://www.cdc.gov/nci-
dod/biotech/strep/strepblast.htm[13]. A total of 25 dif-
ferent emm/st types were detected among the 38 GAS
isolates. Of these 38 isolates, 20 (35%) belonged to 16
validated standard reference emm types [13,14], and 18
isolates (47%) belonged to 9 recognized sequence types
http://www.cdc.gov/ncidod/biotech/strep/strepblast.htm.
To compare the clonal relationships between the iso-
lates, a dendrogram was generated with the UPGMA
algorithm (Fig. 1).
In contrast to most studies in which a large propor-
tion of the GAS isolates belong to a few emm types,
there were no dominant emm types in the present
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order: st3211.0, st0721.0, emm89, emm 75, st4695.0,
st75.0, stIL62.0, and emm78.3) made up 55.4% of the
isolates (Table 1). The most common type, st3211.0,
comprised only 10.5% of the total isolates (4 isolates).
Interestingly, types emm12, emm18, emm3, emm4,
which have remained among the most frequent emm
types for decades in the Western world [15-17], were
absent in this collection. Type emm89, which is frequent
in Canada [17], was also frequent in this study.
emm types of skin and throat isolates
The concept of distinct throat and skin emm types has
been widely accepted. M protein serotypes, such as M
t y p e s1 ,3 ,4 ,5 ,6 ,1 2 ,1 4 ,1 8 ,1 9 ,a n d2 4o fS. pyogenes,
are associated with throat infections [18], while M sero-
types such as 2, 49, 57, 59, 60, and 61 are associated
with impetigo [19]. The number of isolates of each emm
type in the present study is too low make statistical cor-
relations regarding tissue specificity. However, it is
worth noting that a number of emm types with ≥3i s o -
lates, namely st3211.0, stIl62.0, st0721.0, and emm89,
were isolated only from throat samples. One emm type
with two isolates, st4695.0, was isolated only from the
skin.
Discussion
The findings in this study demonstrated that the GAS
isolates from patients in the UAE are highly heteroge-
neous, with 25 distinct emm/st types detected among
the 38 isolates that were collected over a 1-year period.
The number of distinct emm/st types detected in this
study, 25, is not much higher than the number reported
in emm typing studies conducted in other countries that
involved more isolates collected over a longer period of
time[2,16,17,19,20]. In Japan, 29 emm/st types were
detected among 906 clinical isolates collected from 1990
to 1999 [21]. In Mexico, 31 emm types were detected
among 423 isolates collected from symptomatic pharyn-
geal specimens from 1991 to 2000 [20]. In a population-
based study among the Australian aboriginal population,
31 distinct types were reported among 141 isolates col-
lected from the skin and throats of asymptomatic cases
over a 25-month period [8]. In a nationwide survey in
Canada, 54 M serotypes were reported among 4,760
GAS isolates submitted to the national center for strep-
tococci from 1993 to 1999 [17]. In Spain, only 30 differ-
ent emm types were detected among 614 pharyngeal
isolates collected from eight different hospitals over a 4-
year period[22]. The reason for the relatively higher het-
erogeneity observed among the UAE isolates can be
attributed to the heterogeneity of the UAE population
due to many international immigrants.
Since the introduction of the GAS sequence typing
method based on the heterogeneity of the 5’ end of the
emm gene [4,6], several previously undocumented emm
types have been detected. The number of distinct emm/
st types has more than doubled in the last few years, and
currently the CDC database contains over 225 distinct
emm/st types. In the present study, there were no new
emm types among the isolates. This might due to the
small number of isolates. The detection rate of undocu-
mented emm types has varied from country to country.
In general, more new types have been reported in Malay-
sia [9], Thailand [10], Brazil [11], the United States [23],
and Australia [8] compared than in European countries.
The highly diverse nature of the GAS population in
the UAE calls into question the concept of using a mul-
tivalent vaccine composed of the N-terminal regions of
the most common emm types. A multivalent vaccine
composed of 26 M protein N-terminal regions was
anticipated to protect against ca. 90% of the invasive
GAS infections in the United States [24]. Designing an
effective multivalent vaccine based on the N-terminal
Table 1 M protein gene (emm) type distribution in
relation to disease and isolation site.
Site of
isolation
Disease status
emm
type
Total no. of
isolates
% Skin Throat Impetigo Tonsillitis
emm89 3 7.9 3 3
st4695.0 2 5.3 2 2
emm83.8 1 2.6 1 1
emm78.3 2 5.3 2 2
st3211.0 4 10.5 4 4
st75.0 2 5.3 2 2
112.2 1 2.6 1 1
stIL103.1 1 2.6 1 1
emm1 1 2.6 1 1
stIL62.0 2 7.9 2 2
emm75.2 1 2.6 1 1
emm100.5 1 2.6 1 1
emm4.9 1 2.6 1 1
emm4.4 1 2.6 1 1
emm120 1 2.6 1 1
stC6979.1 1 2.6 1 1
st0721.0 3 7.9 3 3
emm75 2 5.3 2 2
stG97.0 1 2.6 1 1
emm71.3 1 2.6 1 1
emm22.1 1 2.6 1 1
emm22 1 2.6 1 1
emm83.1 1 2.6 1 1
st9505.0 1 2.6 1 1
emm87 1 2.6 1 1
Total 38 100 3 35 3 35
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where the GAS population is highly heterogeneous and
the dynamics of streptococcal infections are poorly
understood, presents a challenge. Based on the observa-
tions in the present study, a vaccine with at least 25 dif-
ferent emm type-specific epitopes would be required to
cover ca. 80% of the GAS infections in the UAE.
The aim of this study was to survey the genetic diver-
sity of GAS isolates from the UAE using emm gene
sequence analysis. Our GAS collection contained iso-
lates from the skin and throats of symptomatic indivi-
duals, and the findings demonstrated the highly
heterogeneous nature of the GAS population in the
UAE during the study period. This study is the first of
its kind to be conducted in samples from the UAE, and
it underscores the unique nature of GAS epidemiology
in this region. To better understand the dynamics of
GAS epidemiology in the tropics, further surveillance in
Figure 1 Dendrogram for the 38 GAS emm gene sequences according the the isolate number. The dendrogram was constructed with
Geneious V4.8 sofware, by using the UPGMA algorithm.
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pathogenesis of this bacterium, as well as help design an
appropriate vaccine.
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